Fibronectin-Targeting Dual-Modal MR/NIRF Imaging Contrast Agents for Diagnosis of Gastric Cancer and Peritoneal Metastasis
Bioconjugate Chemistry · 2024
DOI: 10.1021/acs.bioconjchem.4c00208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2024. Verfasst von Ningxin Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Fibronectins, Magnetic Resonance Imaging, Peritoneal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, Shanghai Municipal Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
The prevalence and fatality rates of gastric cancer (GC) remain elevated, with advanced stages presenting a grim prognosis. Noninvasive diagnosis of GC cancer often proves challenging until the disease has progressed to an advanced stage or metastasized. Initially, the level of fibronectin (FN) in cancer-associated fibroblasts (CAFs) of GC was at least 3.7 times higher than that in normal fibroblasts. Herein, two FN-targeting magnetic resonance/near-infrared fluorescence (MR/NIRF) imaging contrast agents were developed to detect GC and peritoneal metastasis noninvasively. The probes CREKA-Cy7-(Gd-DOTA) and CREKA-Cy7-(Gd-DOTA)3 demonstrated significant FN-targeting capability (with dissociation constants of 1.0 and 2.1 mM) and effective MR imaging performance (with proton relaxivity values of 9.66 and 27.44 mM-1 s-1 at 9.4 T, 37 °C). In vivo imaging revealed a high signal-to-noise ratio and successful visualization of GC metastasis using NIRF imaging as well as successful tumor detection in MR imaging. Therefore, this study highlights the potential of FN-targeting probes for GC diagnosis and aids in the advancement of new diagnostic strategies for the clinical detection of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
- Shanghai University of Sport, Shanghai 200438, China.
ORCID-Profile: Dengbin Wang, Defan Yao
Förderung
- Natural Science Foundation of Shanghai Municipality
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Shanghai Rising-Star Program
Zitieren
APA
Yang, N., Huang, Y., Wang, X., Wang, D., Yao, D., & Ren, G. (2024). Fibronectin-Targeting Dual-Modal MR/NIRF Imaging Contrast Agents for Diagnosis of Gastric Cancer and Peritoneal Metastasis. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00208
Vancouver
Yang N, Huang Y, Wang X, Wang D, Yao D, Ren G. Fibronectin-Targeting Dual-Modal MR/NIRF Imaging Contrast Agents for Diagnosis of Gastric Cancer and Peritoneal Metastasis. Bioconjugate Chemistry. 2024. doi:10.1021/acs.bioconjchem.4c00208
BibTeX
@article{Yang2024,
author = {Yang, Ningxin and Huang, Yuelin and Wang, Xiaoyu and Wang, Dengbin and Yao, Defan and Ren, Gang},
title = {Fibronectin-Targeting Dual-Modal MR/NIRF Imaging Contrast Agents for Diagnosis of Gastric Cancer and Peritoneal Metastasis},
journal = {Bioconjugate Chemistry},
year = {2024},
doi = {10.1021/acs.bioconjchem.4c00208}
}
EUVIMED